|
Brain Cancer Research Studies
NEWLY DIAGNOSED
N057K Phase I/II
Evaluation of Everolimus (RAD001), Radiation and Temozolomide (TMZ) Followed by
Adjuvant Temozolomide and Everolimus in Newly Diagnosed Glioblastoma
R0825 Phase III
Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation
and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent
Chemoradiation and Adjuvant Temozolomide in Patients with Newly Diagnosed
Glioblastoma
RECURRENT
N0272 Phase II
Trial of Imatinib Mesylate; (Gleevec; STI-571) in Treatment of Recurrent
Oligodendroglioma and Mixed Oligoastrocytoma
N0572 A Phase
I/II Trial of Sorafenib and CCI-779 in Patients with Recurrent Glioblastoma
N0776 Phase II
Trial of Avastin in Combination with Sorafenib in Recurrent Glioblastoma
Multiforme (temporarily suspended)
LOW GRADE GLIOMA
E3F05 Phase III
Study of Radiation Therapy with or without Temozolomide for Symptomatic or
Progressive Low-Grade Glioma
ANAPLASTIC GLIOMA
N0577 Phase III
Intergroup Study of Radiotherapy Versus Temozoloimde Alone Versus Radiotherapy
with Concomitant and Adjuvant Temozolomide for Patients with 1p/19q Codeleted
Anaplastic Glioma
CANCER CONTROL
WFU-91105 Phase III
Double-Blind, Placebo-Controlled Study of Donepezil in Irradiated Brain Patients
|